Literature DB >> 7238766

The synthesis of enantiomers of 4-ketocyclophosphamide.

K Misiura, K Pankiewicz, W J Stec, M Jarman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238766     DOI: 10.1007/bf01991616

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  6 in total

1.  Ascorbic acid in aromatic hydroxylation. I. A model system for aromatic hydroxylation.

Authors:  S UDENFRIEND; C T CLARK; J AXELROD; B B BRODIE
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

2.  Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.

Authors:  H J Hohorst; G Peter; R F Struck
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

3.  Formation of 4-ketocyclophosphamide by the oxidation of cyclophosphamide with KMnO4.

Authors:  M Jarman
Journal:  Experientia       Date:  1973

4.  4-hydroperoxidatin in the Fenton oxidation of the antitumor agent cyclophosphamide.

Authors:  J Van der Steen; E C Timmer; J G Westra; C Benckhuysen
Journal:  J Am Chem Soc       Date:  1973-10-31       Impact factor: 15.419

5.  Application of deuterium labelling mass spectrometry in a study of the metabolism of the enantiomers of cyclophosphamide.

Authors:  P J Cox; P B Farmer; A B Foster; L J Griggs; M Jarman; R Kinas; K Pankiewicz; W J Stec
Journal:  Biomed Mass Spectrom       Date:  1977-12

6.  Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.

Authors:  M Jarman; R A Milsted; J F Smyth; R W Kinas; K Pankiewicz; W J Stec
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.